Acrux Limited : Lilly comments on Axiron at JP Morgan Healthcare Conference
01/12/2012 | 07:32pm
ACRUX (ACR) - ASX ANNOUNCEMENT 13 JANUARY 2012
LILLY COMMENTS ON AXIRON AT JP MORGAN HEALTHCARE CONFERENCE
Acrux (ASX: ACR) today reported that John Lechleiter,
Chairman, President and CEO of Eli Lilly & Company included
comments on Axiron in a presentation at the JP Morgan
Healthcare Conference in San Francisco. During the
presentation, Dr Lechleiter commented "We've been pleased
with the uptake of Axiron since it was launched last spring.
The most recent IMS data show we've achieved 10% share of
market in total prescriptions and that over one in five new
patient starts are going to Axiron."
Contact
Richard Treagus, CEO: 0417 520 509
About Acrux www.acrux.com.au
